Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre studyOlga Nigro, Corrado Ficorella, Simone Scagnoli et al.|European Journal of Cancer|2020Cited by 71
Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation?Filippo Pesapane, Enrico Cassano, Matteo B. Suter et al.|Medical Oncology|2020Cited by 66
Biopsy and re-biopsy in lung cancer: the oncologist requests and the role of endobronchial ultrasounds transbronchial needle aspirationAlessandro Tuzi, Graziella Pinotti, Elena Bolzacchini et al.|Journal of Thoracic Disease|2017Cited by 16
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumorsMatteo Simonelli, Armando Santoro, Paolo Andrea Zucali et al.|European Journal of Cancer|2012Cited by 13
On-target Toxicities Predictive of Survival in Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: A Multicenter Retrospective StudyElena Bolzacchini, Francesco Dentali, Graziella Pinotti et al.|Clinical Genitourinary Cancer|2019Cited by 7